The shelf registration is now effective, meaning BrainStorm can sell shares at any time, creating an overhang of potential dilution. Monitor for a prospectus supplement or 8-K announcing a specific offering — that would crystallize the dilution. The stock's OTC listing and weak analyst consensus (0% bullish) amplify downside risk from any future issuance.
Price Chart
Executive Summary
BrainStorm Cell Therapeutics' S-1 registration statement (File No. 333-296090) was declared effective by the SEC on June 2, 2026, under the 1933 Act. This allows the company to sell securities under the shelf registration, creating potential dilution overhang for existing shareholders.
Key Facts
- Effectiveness date: June 2, 2026
- SEC File No.: 333-296090
- Registration type: S-1 (shelf registration)
- Company is a clinical-stage biotech with no approved products and trades OTC
- No specific offering size, price, or terms disclosed in the effectiveness notice
Financial Impact
Undisclosed offering size; potential dilution from future share sales under the shelf registration
Risk Factors
- Future share issuance under the shelf could dilute existing holders significantly
- Clinical-stage biotech with no revenue and OTC listing — limited liquidity and high volatility
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001853 |
| Document: 9999999995-26-001853-index.html | 9999999995-26-001853 |
| Document: 9999999995-26-001853.txt | 9999999995-26-001853 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 3, 2026 20w ago | EFFECT | $0.7700 $0.8300 | ▼ −7.79% | ▼ −11.61% | $0.8000 (−3.90%) |
May 28, 2026 21w ago | 8-K | $0.7500 $0.7500 | · 0.00% | ▲ +2.52% | $0.8000 (+6.67%) |
May 15, 2026 23w ago | 8-K | $0.6900 $0.6300 | ▲ +8.70% | ▲ +10.31% | $0.8000 (−15.94%) |
Mar 31, 2026 29w ago | 8-K | $0.9500 $0.9100 | ▼ −4.21% | ▼ −7.98% | $0.8000 (−15.79%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers